Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP617803.RAroCfTxzAFAaZpaz0bb3vZl89bKQTtV6bmihQ-RfLZpA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP617803.RAroCfTxzAFAaZpaz0bb3vZl89bKQTtV6bmihQ-RfLZpA130_assertion type Assertion NP617803.RAroCfTxzAFAaZpaz0bb3vZl89bKQTtV6bmihQ-RfLZpA130_head.
- NP617803.RAroCfTxzAFAaZpaz0bb3vZl89bKQTtV6bmihQ-RfLZpA130_assertion description "[MET activation confers a selective advantage to neoplastic cells in tumor progression and drug resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP617803.RAroCfTxzAFAaZpaz0bb3vZl89bKQTtV6bmihQ-RfLZpA130_provenance.
- NP617803.RAroCfTxzAFAaZpaz0bb3vZl89bKQTtV6bmihQ-RfLZpA130_assertion evidence source_evidence_literature NP617803.RAroCfTxzAFAaZpaz0bb3vZl89bKQTtV6bmihQ-RfLZpA130_provenance.
- NP617803.RAroCfTxzAFAaZpaz0bb3vZl89bKQTtV6bmihQ-RfLZpA130_assertion SIO_000772 20868306 NP617803.RAroCfTxzAFAaZpaz0bb3vZl89bKQTtV6bmihQ-RfLZpA130_provenance.
- NP617803.RAroCfTxzAFAaZpaz0bb3vZl89bKQTtV6bmihQ-RfLZpA130_assertion wasDerivedFrom befree-20140225 NP617803.RAroCfTxzAFAaZpaz0bb3vZl89bKQTtV6bmihQ-RfLZpA130_provenance.
- NP617803.RAroCfTxzAFAaZpaz0bb3vZl89bKQTtV6bmihQ-RfLZpA130_assertion wasGeneratedBy ECO_0000203 NP617803.RAroCfTxzAFAaZpaz0bb3vZl89bKQTtV6bmihQ-RfLZpA130_provenance.